| Name | 6,10,14-trimethylpentadeca-5,9,13-trien-2-ol |
|---|---|
| Synonyms |
5,9,13-Pentadecatrien-2-ol,6,10,14-trimethyl
5E,9E-farnesyl rac-acet-2-ol 5E,9E-farnesyl 2-acetol 5,9,13-Pentadecatrien-2-ol,6,10,14-trimethyl-,(5E,9E) 6,10,14-trimethyl-5,9,13-pentadecatrien-2-ol |
| Molecular Formula | C18H32O |
|---|---|
| Molecular Weight | 264.44600 |
| Exact Mass | 264.24500 |
| PSA | 20.23000 |
| LogP | 5.56660 |
|
~96%
587888-42-4 |
| Literature: COYOTE PHARMACEUTICALS, INC.; SERIZAWA, Hiroaki; ARGADE, Ankush B.; DATWANI, Akash; SPENCER, Natalie; PAN, Yonghua; ERMINI, Florian Patent: WO2013/130654 A1, 2013 ; Location in patent: Paragraph 0389 ; |
|
~%
587888-42-4 |
| Literature: Coyote Pharmaceuticals, Inc.; Serizawa, Hiroaki; Argade, Ankush B.; Datwani, Akash; Spencer, Natalie Patent: US2013/85283 A1, 2013 ; |
|
~%
587888-42-4 |
| Literature: Coyote Pharmaceuticals, Inc.; Serizawa, Hiroaki; Argade, Ankush B.; Datwani, Akash; Spencer, Natalie Patent: US2013/85283 A1, 2013 ; |
|
~%
587888-42-4 |
| Literature: Coyote Pharmaceuticals, Inc.; Serizawa, Hiroaki; Argade, Ankush B.; Datwani, Akash; Spencer, Natalie Patent: US2013/85283 A1, 2013 ; |